Corindus Vascular Robotics has developed a robotic system to improve percutaneous coronary intervention (PCI) placement and reduce health risks to both the patient and the physician.
Browsing: Uncategorized
Delcath’s Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient’s entire body to the anti-cancer drugs.
BioSante Pharmaceuticals may be known for its sexual health products such as LibiGel, but the Illinois-based company is also developing a novel immunotherapy vaccine to treat cancer.
Strategic Medicine (SMI) specializes in patient and disease stratification with the end goals of providing better healthcare and identifying unmet clinical needs.
Imaging, Oncology, Drug Delivery. This company has developed an unprecedented technological platform to enable imaging at the smallest biological scale, the cell. The company’s technology utilizes combinatorial light and sound input to create accurate images of living cells and their inner structures, as well as to measure the electrical characteristics of the cell during intracellular structure interactions and activity. The company’s technology has wide ranging implications as cellular changes are a hallmark of disease, as is seen in the well characterized and consistently seen cellular changes present in cancerous tissue. Furthermore, the company’s technology consists of nanosensors that collect information…
Access Pharmaceuticals (OTC: ACCP.OB, “Access”) develops and commercializes products for the treatment and supportive care of cancer patients.
“Programmed cell death” sounds a bit sinister, but it’s actually a normal and healthy process.
Micrus Endovascular is the only publicly traded company focused on strokes.